PARK MEDI WORLD LIMITED Fair Value
PARKHOSPS · Healthcare · Current price ₹283.1
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹50 | 17% ROE fading to 12% over ~3 yrs, on ₹47 book |
| Relative P/E | ₹387 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹79 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹375 | Street consensus 12-month target price |
Is PARK MEDI WORLD LIMITED undervalued?
DocStoX estimates the fair value of PARK MEDI WORLD LIMITED at ₹190 per share, versus the current market price of ₹283. That puts the stock about -32.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹50), Relative P/E (₹387), Graham floor (₹79), Analyst target (₹375). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹50 (bear) to ₹190 (base) to ₹387 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on PARK MEDI WORLD LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.